Stockscreener 앱 받기
3.52
2.62%
0.09
시간 외 거래:
3.46
-0.06
-1.70%
전일 마감가:
$3.43
열려 있는:
$3.45
하루 거래량:
3.59M
Relative Volume:
1.29
시가총액:
$1.07B
수익:
$248.37M
순이익/손실:
$11.74M
주가수익비율:
70.40
EPS:
0.05
순현금흐름:
$18.24M
1주 성능:
-6.13%
1개월 성능:
-2.76%
6개월 성능:
-37.48%
1년 성능:
-32.18%
1일 변동 폭
$3.45
$3.59
1주일 범위
$3.40
$4.07
52주 변동 폭
$3.40
$7.63
맨카인드 Stock (MNKD) Company Profile
명칭
Mannkind Corp
전화
818-661-5000
주소
1 CASPER STREET, DANBURY, CA
MNKD을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
MNKD
Mannkind Corp
|
3.52 | 1.06B | 248.37M | 11.74M | 18.24M | 0.05 |
|
VRTX
Vertex Pharmaceuticals Inc
|
366.54 | 98.88B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.00 | 58.84B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
438.93 | 56.12B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
661.83 | 41.20B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
288.18 | 35.49B | 3.81B | -644.79M | -669.77M | -6.24 |
맨카인드 Stock (MNKD) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-16 | 재개 | H.C. Wainwright | Buy |
| 2025-04-10 | 개시 | Mizuho | Outperform |
| 2025-02-10 | 개시 | Wedbush | Outperform |
| 2024-12-20 | 개시 | Wells Fargo | Overweight |
| 2024-12-19 | 업그레이드 | RBC Capital Mkts | Sector Perform → Outperform |
| 2024-09-09 | 재개 | Leerink Partners | Outperform |
| 2024-06-13 | 개시 | Rodman & Renshaw | Buy |
| 2023-10-10 | 개시 | Wedbush | Outperform |
| 2021-05-14 | 개시 | RBC Capital Mkts | Sector Perform |
| 2019-12-24 | 개시 | Oppenheimer | Outperform |
| 2019-10-25 | 개시 | Cantor Fitzgerald | Overweight |
| 2019-05-14 | 개시 | BTIG Research | Buy |
| 2019-03-04 | 개시 | SVB Leerink | Outperform |
| 2019-02-22 | 개시 | SVB Leerink | Outperform |
| 2018-02-28 | 다운그레이드 | Maxim Group | Hold → Sell |
| 2017-11-01 | 다운그레이드 | Maxim Group | Buy → Hold |
| 2017-10-10 | 개시 | H.C. Wainwright | Buy |
| 2017-10-06 | 재확인 | Maxim Group | Buy |
| 2017-08-11 | 개시 | Maxim Group | Buy |
| 2016-05-10 | 재확인 | Piper Jaffray | Underweight |
| 2016-05-10 | 재확인 | RBC Capital Mkts | Underperform |
| 2016-01-06 | 재확인 | Piper Jaffray | Underweight |
| 2016-01-06 | 재확인 | RBC Capital Mkts | Underperform |
| 2015-11-04 | 다운그레이드 | RBC Capital Mkts | Outperform → Underperform |
| 2015-09-09 | 다운그레이드 | Piper Jaffray | Neutral → Underweight |
| 2015-08-03 | 재확인 | RBC Capital Mkts | Outperform |
| 2015-05-11 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2015-05-11 | 재확인 | MLV & Co | Hold |
| 2015-04-16 | 재확인 | RBC Capital Mkts | Outperform |
모두보기
맨카인드 주식(MNKD)의 최신 뉴스
ISCG's Underlying Holdings Predict 18% Gain Potential - AInvest
MannKind Corporation (NASDAQ:MNKD) Q2 2025 Earnings Call Transcript - Insider Monkey
MannKind Corporation: A Post-Q2 2025 Deep Dive — Is This the Catalyst-Driven Turnaround Play Investors Have Been Waiting For? - AInvest
MannKind And Blackstone Announce Up To $500 Mln Strategic Financing Agreement - Nasdaq
MannKind Corporation Reports Second Quarter 2025 Financial Results And Provides Business Update - GlobeNewswire
MannKind shares tumble as revenue misses expectations By Investing.com - Investing.com South Africa
MannKind shares tumble as revenue misses expectations - Investing.com
Earnings call transcript: MannKind Q2 2025 results see mixed market reaction - Investing.com India
MannKind (MNKD) Q2 Revenue Rises 6% - The Motley Fool
MannKind (MNKD) Secures $500 Million Strategic Financing from Bl - GuruFocus
MannKind Corp stock hits 52-week low at 3.5 USD By Investing.com - Investing.com Australia
MannKind Corp stock hits 52-week low at 3.5 USD - Investing.com India
MannKind Corp reports results for the quarter ended June 30Earnings Summary - TradingView
MannKind (MNKD) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates - Yahoo Finance
MannKind Announces $500M Financing Agreement With Blackstone After Q2 Revenue Miss: Retail Believes Stock Is ‘Ridiculously Undervalued’ - Stocktwits
MannKind (MNKD) Reports Break-Even Earnings for Q2 - Yahoo Finance
MannKind and Blackstone Announce up to $500 Million Strategic Financing Agreement - The Manila Times
MannKind secures up to $500 million strategic financing from Blackstone - Investing.com
MannKind Corporation Secures Up to $500 Million Strategic Financing Agreement with Blackstone - Quiver Quantitative
MannKind Corporation Reports Second Quarter 2025 Financial Results - TradingView
MannKind Secures Massive $500M Blackstone Backing: $75M Immediate Funding for Inhaled Therapeutics Growth - Stock Titan
Wedbush Maintains a Buy on MannKind Corporation (MNKD) - Insider Monkey
10 Best Strong Buy Penny Stocks to Buy Now - Insider Monkey
INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders of MannKind Corp. of Class Action Lawsuit and a Lead Plaintiff Deadline of March 15, 2016MNKD - ACCESS Newswire
H.C. Wainwright Affirms MannKind Corp (MNKD)’s ‘Buy’ Rating Buoyed by Product Pipeline - Insider Monkey
MannKind Corporation Receives 'Buy' Rating from H.C. Wainwright Amid Strong Growth and Promising Product Pipeline - AInvest
MannKind Corporation’s Global Supply Chain Risks: Navigating Trade Policies and Financial Challenges - The Globe and Mail
Wedbush Remains Bullish on MannKind Corporation (MNKD) - Insider Monkey
14 Best Biotech Penny Stocks to Buy Right Now - Insider Monkey
10 Penny Stocks That Will Skyrocket - Insider Monkey
MannKind Corporation to Release Second Quarter 2025 Financial Results and Host Webcast on August 6, 2025 - Quiver Quantitative
MannKind Corporation to Hold 2025 Second Quarter Financial Results Conference Call on August 6, 2025 - GlobeNewswire
What makes MannKind Corporation stock price move sharplyMomentum Based Equity Trading Plans Reviewed - metal.it
Analysts Estimate MannKind (MNKD) to Report a Decline in Earnings: What to Look Out for - Yahoo Finance
AI Tools Suggest MannKind Corporation May Outperform This WeekChart Driven High Reward Trading Setup Presented - metal.it
Why is MannKind Corporation stock attracting strong analyst attentionFree Daily Trading Room Entry - Jammu Links News
How volatile is MannKind Corporation stock compared to the marketCapitalize on fast-moving stock opportunities - Jammu Links News
RBC Capital Lowered the PT on MannKind Corporation (MNKD), Kept a Buy Rating - Insider Monkey
How MannKind Corporation stock performs during market volatilityCapital Safe Smart Trades - metal.it
7 High Growth Penny Stocks That Are Profitable in 2025 - Insider Monkey
What drives MannKind Corporation stock priceFree Stock Selection - PrintWeekIndia
MannKind stock price target lowered to $8 at RBC Capital on model updates - Investing.com Canada
MannKind Corporation (MNKD) Presented Inhaled Insulin Therapy At American Diabetes Association - Insider Monkey
What analysts say about MannKind Corporation stockLightning-fast capital gains - jammulinksnews.com
11 Best American Penny Stocks to Buy According to Analysts - Insider Monkey
MannKind Corporation Stock Analysis and ForecastBreakthrough profits - jammulinksnews.com
MannKind (NASDAQ:MNKD) Upgraded at HC Wainwright - Defense World
Mannkind director Binder sells $296945 in shares By Investing.com - Investing.com India
MannKind Corp Executives Sell Shares Amid Recent Price Declines - AInvest
H.C. Wainwright assumes coverage on MannKind stock with Buy rating - Investing.com
H.C. Wainwright assumes coverage on MannKind stock with Buy rating By Investing.com - Investing.com Canada
맨카인드 (MNKD) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.24%
3.39%
자본화:
|
볼륨(24시간):